Mobix Labs shareholders approve all proposals at annual meeting

Mobix Labs approved a reverse stock split and elected directors at its annual meeting; shares trade at $0.46 with a $47.29M market cap and the stock is down ~43% over the last six months. All four proposals passed (reverse split: 61,593,771 for vs 2,357,828 against; auditor ratified 62,399,491 for; warrants approved), with ~52.86% of voting power present and no broker non-votes. The company reported LTM EPS of -$0.71 and is described as 'quickly burning through cash,' indicating financial stress despite recent shareholder approvals. Mobix also disclosed multiple defense and aerospace production wins — including a production purchase order for Tomahawk cruise missile components, communications hardware for U.S. Navy ships, Gulfstream aircraft components, and selection for an anti-drone feasibility program — which provide near-term revenue opportunities.

Analysis

The recent governance toolkit (share consolidation + warrant authorization) is classic microcap capital-structure engineering: it raises the probability of a near-term technical squeeze as float compresses, but materially increases the chance of equity-linked dilution within 3–9 months. Practically, that creates a two-phase price path: an asymmetric short-term pop if market makers/retail chase scarcity, followed by a downside leg when financing or warrant issuance materializes. Position sizing should reflect this bifurcation.

Defense program wins shift the revenue mix from ad hoc commercial sales to lumpy, prime-led procurements; that improves visibility only if the company can align working-capital and production cadence with prime invoicing terms. Second-order beneficiaries include mid-tier contract manufacturers and high-reliability component suppliers that can scale to meet Tomahawk-level QA — expect order flow concentration toward vendors with existing DoD QPLs, pressuring smaller competitors.

From a balance-sheet standpoint, negative cash flow trends make a dilutive capital raise the path of least resistance absent a strategic OEM equity anchor. Catalysts that could invalidate the bearish path are concrete backlog-to-revenue conversion (book-to-bill reported within 30–90 days) or a strategic JV with a prime that brings non-dilutive funding. Tail risks include program de-scoping, prime consolidation, or multi-quarter delays in Navy approvals, which would compress valuation sharply over 3–12 months.

Key Decisions for Investors

• Short MOBXW (warrants) — tactical 0–3 month trade size 1–2% NAV. Rationale: high probability of near-term dilution or exercise-adjustment that collapses warrant implied value. Target 40–60% return; hard stop if warrants rally >30% from current levels (cap loss) given asymmetric leverage.
• Small long equity tranche in MOBX — 30–90 day event play (size 0.5–1% NAV). Buy ahead of expected production/billing milestones; take profits on confirmed PO-to-invoice news. Risk: 50% downside if financing/dilution occurs; mitigate with protective puts or tight stop at -30%.
• Pair trade: long APH or TEL (1–3% NAV) vs short MOBX (1% NAV) for 3–12 months. Rationale: secular defense electronics demand concentrates revenue to scalable suppliers while smaller players face margin/cash constraints. Target asymmetric 2:1 reward:risk over 6–12 months.
• Event hedge: if a shelf/equity filing appears, buy 3–6 month MOBX puts or increase short exposure immediately. Filing-to-deal execution historically erodes small-cap equity 20–40% in weeks; trade aims to capture the initial repricing.